ImmunoGen, Inc. (NASDAQ:IMGN) Q4 2022 Earnings Call Transcript March 1, 2023
Operator: Good morning, and welcome to ImmunoGen’s Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. Today’s conference is being recorded. At this time, I’d like to turn the call over to Anabel Chan, Head of Investor Relations. Please go ahead.
Anabel Chan: Good morning, and thank you for joining today’s call. Earlier today, we issued a press release that includes a summary of our...
